Announced
Synopsis
capiton, an investment company in Berlin, agreed to acquire CNP Pharma, an international manufacturer and distributor of generic pharmaceuticals. Financial terms were not disclosed. capiton acquired CNP Group from the founding family together with the management team as well as senior industry experts. Financing of the transaction is provided by capiton’s current investment vehicle, capiton VI. Additional funds have been reserved to finance both organic and inorganic growth initiatives in Germany and abroad.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.